TY - JOUR AU - Reid, B. M. AU - Permuth, J. B. AU - Sellers, T. A. PY - 2017 DA - 2017// TI - Epidemiology of ovarian cancer: a review JO - Cancer Biol Med VL - 14 UR - https://doi.org/10.20892/j.issn.2095-3941.2016.0084 DO - 10.20892/j.issn.2095-3941.2016.0084 ID - Reid2017 ER - TY - JOUR AU - Hennessy, B. T. AU - Coleman, R. L. AU - Markman, M. PY - 2009 DA - 2009// TI - Ovarian cancer JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)61338-6 DO - 10.1016/S0140-6736(09)61338-6 ID - Hennessy2009 ER - TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2015 DA - 2015// TI - Cancer statistics, 2015 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21254 DO - 10.3322/caac.21254 ID - Siegel2015 ER - TY - JOUR AU - Bookman, M. A. PY - 2016 DA - 2016// TI - Optimal primary therapy of ovarian cancer JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw088 DO - 10.1093/annonc/mdw088 ID - Bookman2016 ER - TY - JOUR AU - Bergamini, A. AU - Pisano, C. AU - Napoli, M. AU - Arenare, L. AU - Della Pepa, C. AU - Tambaro, R. PY - 2017 DA - 2017// TI - Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin JO - Gynecol Oncol VL - 144 UR - https://doi.org/10.1016/j.ygyno.2016.10.023 DO - 10.1016/j.ygyno.2016.10.023 ID - Bergamini2017 ER - TY - JOUR AU - Davis, A. AU - Tinker, A. V. AU - Friedlander, M. PY - 2014 DA - 2014// TI - “Platinum resistant” ovarian cancer: what is it, who to treat and how to measure benefit? JO - Gynecol Oncol VL - 133 UR - https://doi.org/10.1016/j.ygyno.2014.02.038 DO - 10.1016/j.ygyno.2014.02.038 ID - Davis2014 ER - TY - JOUR AU - Farmer, H. AU - McCabe, N. AU - Lord, C. J. AU - Tutt, A. N. AU - Johnson, D. A. AU - Richardson, T. B. PY - 2005 DA - 2005// TI - Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy JO - Nature VL - 434 UR - https://doi.org/10.1038/nature03445 DO - 10.1038/nature03445 ID - Farmer2005 ER - TY - JOUR AU - Wiltshire, T. D. AU - Lovejoy, C. A. AU - Wang, T. AU - Xia, F. AU - O’Connor, M. J. AU - Cortez, D. PY - 2010 DA - 2010// TI - Sensitivity to poly(ADP-ribose) polymerase (PARP) inhibition identifies ubiquitin-specific peptidase 11 (USP11) as a regulator of DNA double-strand break repair JO - J Biol Chem VL - 285 UR - https://doi.org/10.1074/jbc.M110.104745 DO - 10.1074/jbc.M110.104745 ID - Wiltshire2010 ER - TY - JOUR AU - Murai, J. AU - Huang, S. Y. AU - Das, B. B. AU - Renaud, A. AU - Zhang, Y. AU - Doroshow, J. H. PY - 2012 DA - 2012// TI - Trapping of PARP1 and PARP2 by clinical PARP inhibitors JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-12-2753 DO - 10.1158/0008-5472.CAN-12-2753 ID - Murai2012 ER - TY - JOUR AU - Kaufman, B. AU - Shapira-Frommer, R. AU - Schmutzler, R. K. AU - Audeh, M. W. AU - Friedlander, M. AU - Balmaña, J. PY - 2015 DA - 2015// TI - Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.56.2728 DO - 10.1200/JCO.2014.56.2728 ID - Kaufman2015 ER - TY - JOUR AU - Tan, D. S. P. AU - Rothermundt, C. AU - Thomas, K. AU - Bancroft, E. AU - Eeles, R. AU - Shanley, S. PY - 2008 DA - 2008// TI - “BRCAness” syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.16.1703 DO - 10.1200/JCO.2008.16.1703 ID - Tan2008 ER - TY - JOUR AU - Turner, N. AU - Tutt, A. AU - Ashworth, A. PY - 2004 DA - 2004// TI - Hallmarks of “BRCAness” in sporadic cancers JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1457 DO - 10.1038/nrc1457 ID - Turner2004 ER - TY - JOUR AU - Barber, L. J. AU - Sandhu, S. AU - Chen, L. AU - Campbell, J. AU - Kozarewa, I. AU - Fenwick, K. PY - 2013 DA - 2013// TI - Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor JO - J Pathol VL - 229 UR - https://doi.org/10.1002/path.4140 DO - 10.1002/path.4140 ID - Barber2013 ER - TY - JOUR AU - Johnson, N. AU - Johnson, S. F. AU - Yao, W. AU - Li, Y. C. AU - Choi, Y. E. AU - Bernhardy, A. J. PY - 2013 DA - 2013// TI - Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1305170110 DO - 10.1073/pnas.1305170110 ID - Johnson2013 ER - TY - JOUR AU - Tapodi, A. AU - Debreceni, B. AU - Hanto, K. AU - Bognar, Z. AU - Wittmann, I. AU - Gallyas, F. PY - 2005 DA - 2005// TI - Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M507075200 DO - 10.1074/jbc.M507075200 ID - Tapodi2005 ER - TY - JOUR AU - Moskwa, P. AU - Buffa, F. M. AU - Pan, Y. AU - Panchakshari, R. AU - Gottipati, P. AU - Muschel, R. J. PY - 2011 DA - 2011// TI - miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors JO - Mol Cell VL - 41 UR - https://doi.org/10.1016/j.molcel.2010.12.005 DO - 10.1016/j.molcel.2010.12.005 ID - Moskwa2011 ER - TY - JOUR AU - Neijenhuis, S. AU - Bajrami, I. AU - Miller, R. AU - Lord, C. J. AU - Ashworth, A. PY - 2013 DA - 2013// TI - Identification of miRNA modulators to PARP inhibitor response JO - DNA Repair (Amst) VL - 12 UR - https://doi.org/10.1016/j.dnarep.2013.02.003 DO - 10.1016/j.dnarep.2013.02.003 ID - Neijenhuis2013 ER - TY - JOUR AU - Choi, Y. E. AU - Meghani, K. AU - Brault, M. E. AU - Leclerc, L. AU - He, Y. J. AU - Day, T. A. PY - 2016 DA - 2016// TI - Platinum and PARP inhibitor resistance due to overexpression of MicroRNA-622 in BRCA1-mutant ovarian Cancer JO - Cell Rep VL - 14 UR - https://doi.org/10.1016/j.celrep.2015.12.046 DO - 10.1016/j.celrep.2015.12.046 ID - Choi2016 ER - TY - JOUR AU - Ellis, L. M. PY - 2006 DA - 2006// TI - The role of neuropilins in cancer JO - Mol Cancer Ther VL - 5 UR - https://doi.org/10.1158/1535-7163.MCT-05-0538 DO - 10.1158/1535-7163.MCT-05-0538 ID - Ellis2006 ER - TY - JOUR AU - Hu, B. AU - Guo, P. AU - Bar-Joseph, I. AU - Imanishi, Y. AU - Jarzynka, M. J. AU - Bogler, O. PY - 2007 DA - 2007// TI - Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210348 DO - 10.1038/sj.onc.1210348 ID - Hu2007 ER - TY - JOUR AU - Lu, Y. AU - Xiang, H. AU - Liu, P. AU - Tong, R. R. AU - Watts, R. J. AU - Koch, A. W. PY - 2009 DA - 2009// TI - Identification of circulating neuropilin-1 and dose-dependent elevation following anti-neuropilin-1 antibody administration JO - MAbs VL - 1 UR - https://doi.org/10.4161/mabs.1.4.8885 DO - 10.4161/mabs.1.4.8885 ID - Lu2009 ER - TY - JOUR AU - Yu, D. C. AU - Waby, J. S. AU - Chirakkal, H. AU - Staton, C. A. AU - Corfe, B. M. PY - 2010 DA - 2010// TI - Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation JO - Mol Cancer VL - 9 UR - https://doi.org/10.1186/1476-4598-9-276 DO - 10.1186/1476-4598-9-276 ID - Yu2010 ER - TY - JOUR AU - Neufeld, G. AU - Cohen, T. AU - Shraga, N. AU - Lange, T. AU - Kessler, O. AU - Herzog, Y. PY - 2002 DA - 2002// TI - The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis JO - Trends Cardiovasc Med VL - 12 UR - https://doi.org/10.1016/S1050-1738(01)00140-2 DO - 10.1016/S1050-1738(01)00140-2 ID - Neufeld2002 ER - TY - JOUR AU - Ohsaka, A. AU - Hirota-Komatsu, S. AU - Araki, M. AU - Komatsu, N. PY - 2015 DA - 2015// TI - Platelet-derived growth factor receptors form complexes with neuropilin-1 during megakaryocytic differentiation of thrombopoietin-dependent UT-7/TPO cells JO - Biochem Biophys Res Commun VL - 459 UR - https://doi.org/10.1016/j.bbrc.2015.02.124 DO - 10.1016/j.bbrc.2015.02.124 ID - Ohsaka2015 ER - TY - JOUR AU - Ceccarelli, S. AU - Nodale, C. AU - Vescarelli, E. AU - Pontecorvi, P. AU - Manganelli, V. AU - Casella, G. PY - 2018 DA - 2018// TI - Neuropilin 1 mediates keratinocyte growth factor signaling in adipose-derived stem cells: potential involvement in Adipogenesis JO - Stem Cells Int VL - 2018 UR - https://doi.org/10.1155/2018/1075156 DO - 10.1155/2018/1075156 ID - Ceccarelli2018 ER - TY - JOUR AU - Hong, T. M. AU - Chen, Y. L. AU - Wu, Y. Y. AU - Yuan, A. AU - Chao, Y. C. AU - Chung, Y. C. PY - 2007 DA - 2007// TI - Targeting neuropilin 1 as an antitumor strategy in lung cancer JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-0001 DO - 10.1158/1078-0432.CCR-07-0001 ID - Hong2007 ER - TY - JOUR AU - Pan, Q. AU - Chathery, Y. AU - Wu, Y. AU - Rathore, N. AU - Tong, R. K. AU - Peale, F. PY - 2007 DA - 2007// TI - Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M703554200 DO - 10.1074/jbc.M703554200 ID - Pan2007 ER - TY - JOUR AU - Stephenson, J. M. AU - Banerjee, S. AU - Saxena, N. K. AU - Cherian, R. AU - Banerjee, S. K. PY - 2002 DA - 2002// TI - Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: a possible marker for the progression of breast cancer JO - Int J Cancer VL - 101 UR - https://doi.org/10.1002/ijc.10611 DO - 10.1002/ijc.10611 ID - Stephenson2002 ER - TY - JOUR AU - Kreuter, M. AU - Woelke, K. AU - Bieker, R. AU - Schliemann, C. AU - Steins, M. AU - Buechner, T. PY - 2006 DA - 2006// TI - Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia JO - Leukemia VL - 20 UR - https://doi.org/10.1038/sj.leu.2404384 DO - 10.1038/sj.leu.2404384 ID - Kreuter2006 ER - TY - JOUR AU - Wey, J. S. AU - Gray, M. J. AU - Fan, F. AU - Belcheva, A. AU - McCarty, M. F. AU - Stoeltzing, O. PY - 2005 DA - 2005// TI - Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells JO - Br J Cancer VL - 93 UR - https://doi.org/10.1038/sj.bjc.6602663 DO - 10.1038/sj.bjc.6602663 ID - Wey2005 ER - TY - JOUR AU - Vanveldhuizen, P. J. AU - Zulfiqar, M. AU - Banerjee, S. AU - Cherian, R. AU - Saxena, N. K. AU - Rabe, A. PY - 2003 DA - 2003// TI - Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue JO - Oncol Rep VL - 10 ID - Vanveldhuizen2003 ER - TY - JOUR AU - Jiang, H. AU - Xi, Q. AU - Wang, F. AU - Sun, Z. AU - Huang, Z. AU - Qi, L. PY - 2015 DA - 2015// TI - Increased expression of neuropilin 1 is associated with epithelial ovarian carcinoma JO - Mol Med Rep VL - 12 UR - https://doi.org/10.3892/mmr.2015.3580 DO - 10.3892/mmr.2015.3580 ID - Jiang2015 ER - TY - JOUR AU - Osada, H. AU - Tokunaga, T. AU - Nishi, M. AU - Hatanaka, H. AU - Abe, Y. AU - Tsugu, A. PY - 2004 DA - 2004// TI - Overexpression of the Neuropilin 1 (NRP1) gene correlated with poor prognosis in human Glioma JO - Anticancer Res VL - 24 ID - Osada2004 ER - TY - JOUR AU - Baba, T. AU - Kariya, M. AU - Higuchi, T. AU - Mandai, M. AU - Matsumura, N. AU - Kondoh, E. PY - 2007 DA - 2007// TI - Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition JO - Gynecol Oncol VL - 105 UR - https://doi.org/10.1016/j.ygyno.2007.02.005 DO - 10.1016/j.ygyno.2007.02.005 ID - Baba2007 ER - TY - JOUR AU - Siamakpour-Reihani, S. AU - Owzar, K. AU - Jiang, C. AU - Turner, T. AU - Deng, Y. AU - Bean, S. M. PY - 2015 DA - 2015// TI - Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma JO - Gynecol Oncol VL - 139 UR - https://doi.org/10.1016/j.ygyno.2015.08.001 DO - 10.1016/j.ygyno.2015.08.001 ID - Siamakpour-Reihani2015 ER - TY - JOUR AU - Chen, C. AU - Hu, Y. AU - Li, L. PY - 2016 DA - 2016// TI - NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis JO - Mol Med Rep VL - 13 UR - https://doi.org/10.3892/mmr.2015.4556 DO - 10.3892/mmr.2015.4556 ID - Chen2016 ER - TY - JOUR AU - Filipowicz, W. AU - Bhattacharyya, S. N. AU - Sonenberg, N. PY - 2008 DA - 2008// TI - Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? JO - Nat Rev Genet VL - 9 UR - https://doi.org/10.1038/nrg2290 DO - 10.1038/nrg2290 ID - Filipowicz2008 ER - TY - JOUR AU - Bartel, D. P. PY - 2004 DA - 2004// TI - MicroRNAs: genomics, biogenesis, mechanism, and function JO - Cell VL - 116 UR - https://doi.org/10.1016/S0092-8674(04)00045-5 DO - 10.1016/S0092-8674(04)00045-5 ID - Bartel2004 ER - TY - JOUR AU - Jansson, M. D. AU - Lund, A. H. PY - 2012 DA - 2012// TI - MicroRNA and cancer JO - Mol Oncol VL - 6 UR - https://doi.org/10.1016/j.molonc.2012.09.006 DO - 10.1016/j.molonc.2012.09.006 ID - Jansson2012 ER - TY - JOUR AU - Anastasiadou, E. AU - Faggioni, A. AU - Trivedi, P. AU - Slack, F. J. PY - 2018 DA - 2018// TI - The nefarious nexus of noncoding RNAs in cancer JO - Int J Mol Sci VL - 19 UR - https://doi.org/10.3390/ijms19072072 DO - 10.3390/ijms19072072 ID - Anastasiadou2018 ER - TY - JOUR AU - Szafranska, A. E. AU - Davison, T. S. AU - John, J. AU - Cannon, T. AU - Sipos, B. AU - Maghnouj, A. PY - 2007 DA - 2007// TI - MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210228 DO - 10.1038/sj.onc.1210228 ID - Szafranska2007 ER - TY - JOUR AU - Hayes, J. AU - Peruzzi, P. P. AU - Lawler, S. PY - 2014 DA - 2014// TI - MicroRNAs in cancer: biomarkers, functions and therapy JO - Trends Mol Med VL - 20 UR - https://doi.org/10.1016/j.molmed.2014.06.005 DO - 10.1016/j.molmed.2014.06.005 ID - Hayes2014 ER - TY - JOUR AU - Bader, A. G. AU - Brown, D. AU - Winkler, M. PY - 2010 DA - 2010// TI - The promise of microRNA replacement therapy JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-2010 DO - 10.1158/0008-5472.CAN-10-2010 ID - Bader2010 ER - TY - JOUR AU - Liu, Q. AU - Xu, Y. AU - Wei, S. AU - Gao, W. AU - Chen, L. AU - Zhou, T. PY - 2015 DA - 2015// TI - miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1 JO - Biosci Rep VL - 35 UR - https://doi.org/10.1042/BSR20150084 DO - 10.1042/BSR20150084 ID - Liu2015 ER - TY - JOUR AU - Zhang, G. AU - Chen, L. AU - Khan, A. A. AU - Li, B. AU - Gu, B. AU - Lin, F. PY - 2018 DA - 2018// TI - miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis JO - Int J Cancer VL - 143 UR - https://doi.org/10.1002/ijc.31329 DO - 10.1002/ijc.31329 ID - Zhang2018 ER - TY - JOUR AU - Zhu, H. AU - Jiang, X. AU - Zhou, X. AU - Dong, X. AU - Xie, K. AU - Yang, C. PY - 2018 DA - 2018// TI - Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells JO - Liver Int VL - 38 UR - https://doi.org/10.1111/liv.13495 DO - 10.1111/liv.13495 ID - Zhu2018 ER - TY - JOUR AU - Ma, L. AU - Zhai, B. AU - Zhu, H. AU - Li, W. AU - Jiang, W. AU - Lei, L. PY - 2019 DA - 2019// TI - The miR-141/neuropilin-1 axis is associated with the clinicopathology and contributes to the growth and metastasis of pancreatic cancer JO - Cancer Cell Int VL - 19 UR - https://doi.org/10.1186/s12935-018-0719-4 DO - 10.1186/s12935-018-0719-4 ID - Ma2019 ER - TY - JOUR AU - Iorio, M. V. AU - Visone, R. AU - Leva, G. AU - Donati, V. AU - Petrocca, F. AU - Casalini, P. PY - 2007 DA - 2007// TI - MicroRNA signatures in human ovarian cancer JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-07-1936 DO - 10.1158/0008-5472.CAN-07-1936 ID - Iorio2007 ER - TY - JOUR AU - Kan, C. W. S. AU - Hahn, M. A. AU - Gard, G. B. AU - Maidens, J. AU - Huh, J. Y. AU - Marsh, D. J. PY - 2012 DA - 2012// TI - Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer JO - BMC Cancer VL - 12 UR - https://doi.org/10.1186/1471-2407-12-627 DO - 10.1186/1471-2407-12-627 ID - Kan2012 ER - TY - JOUR AU - Cao, Q. AU - Lu, K. AU - Dai, S. AU - Hu, Y. AU - Fan, W. PY - 2014 DA - 2014// TI - Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer JO - Int J Clin Exp Pathol VL - 7 ID - Cao2014 ER - TY - JOUR AU - Sulaiman, S. A. AU - Ab Mutalib, N. -. S. AU - Jamal, R. PY - 2016 DA - 2016// TI - miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition JO - Front Pharmacol VL - 7 UR - https://doi.org/10.3389/fphar.2016.00271 DO - 10.3389/fphar.2016.00271 ID - Sulaiman2016 ER - TY - JOUR AU - Mutlu, M. AU - Raza, U. AU - Saatci, Ö. AU - Eyüpoğlu, E. AU - Yurdusev, E. AU - Şahin, Ö. PY - 2016 DA - 2016// TI - miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance JO - J Mol Med VL - 94 UR - https://doi.org/10.1007/s00109-016-1420-5 DO - 10.1007/s00109-016-1420-5 ID - Mutlu2016 ER - TY - JOUR AU - Cochrane, D. R. AU - Howe, E. N. AU - Spoelstra, N. S. AU - Richer, J. K. PY - 2010 DA - 2010// TI - Loss of miR-200c: a marker of aggressiveness and Chemoresistance in female reproductive cancers JO - J Oncol VL - 2010 UR - https://doi.org/10.1155/2010/821717 DO - 10.1155/2010/821717 ID - Cochrane2010 ER - TY - JOUR AU - Lin, C. H. AU - Jackson, A. L. AU - Guo, J. AU - Linsley, P. S. AU - Eisenman, R. N. PY - 2009 DA - 2009// TI - Myc-regulated microRNAs attenuate embryonic stem cell differentiation JO - EMBO J VL - 28 UR - https://doi.org/10.1038/emboj.2009.254 DO - 10.1038/emboj.2009.254 ID - Lin2009 ER - TY - JOUR AU - Ceccarelli, S. AU - D’Amici, S. AU - Vescarelli, E. AU - Coluccio, P. AU - Matricardi, P. AU - Gioia, C. PY - 2014 DA - 2014// TI - Topical KGF treatment as a therapeutic strategy for vaginal atrophy in a model of ovariectomized mice JO - J Cell Mol Med VL - 18 UR - https://doi.org/10.1111/jcmm.12334 DO - 10.1111/jcmm.12334 ID - Ceccarelli2014 ER - TY - JOUR AU - Rotolo, S. AU - Ceccarelli, S. AU - Romano, F. AU - Frati, L. AU - Marchese, C. AU - Angeloni, A. PY - 2008 DA - 2008// TI - Silencing of keratinocyte growth factor receptor restores 5-fluorouracil and Tamoxifen efficacy on responsive Cancer cells JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0002528 DO - 10.1371/journal.pone.0002528 ID - Rotolo2008 ER - TY - JOUR AU - D’Amici, S. AU - Ceccarelli, S. AU - Vescarelli, E. AU - Romano, F. AU - Frati, L. AU - Marchese, C. PY - 2013 DA - 2013// TI - TNF alpha modulates fibroblast growth factor receptor 2 gene expression through the pRB/E2F1 pathway: identification of a non-canonical E2F binding motif JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0061491 DO - 10.1371/journal.pone.0061491 ID - D’Amici2013 ER - TY - JOUR AU - Li, A. J. AU - Karlan, B. Y. PY - 2001 DA - 2001// TI - Genetic factors in ovarian carcinoma JO - Curr Oncol Rep VL - 3 UR - https://doi.org/10.1007/s11912-001-0039-y DO - 10.1007/s11912-001-0039-y ID - Li2001 ER - TY - JOUR AU - Audeh, M. W. AU - Carmichael, J. AU - Penson, R. T. AU - Friedlander, M. AU - Powell, B. AU - Bell-McGuinn, K. M. PY - 2010 DA - 2010// TI - Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial JO - Lancet VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)60893-8 DO - 10.1016/S0140-6736(10)60893-8 ID - Audeh2010 ER - TY - JOUR AU - Fong, P. C. AU - Yap, T. A. AU - Boss, D. S. AU - Carden, C. P. AU - Mergui-Roelvink, M. AU - Gourley, C. PY - 2010 DA - 2010// TI - Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.9589 DO - 10.1200/JCO.2009.26.9589 ID - Fong2010 ER - TY - JOUR AU - Bourton, E. C. AU - Ahorner, P. A. AU - Plowman, P. N. AU - Zahir, S. A. AU - Al-Ali, H. AU - Parris, C. N. PY - 2017 DA - 2017// TI - The PARP-1 inhibitor Olaparib suppresses BRCA1 protein levels, increases apoptosis and causes radiation hypersensitivity in BRCA1+/− lymphoblastoid cells JO - J Cancer VL - 8 UR - https://doi.org/10.7150/jca.21338 DO - 10.7150/jca.21338 ID - Bourton2017 ER - TY - JOUR AU - Rodriguez-Rocha, H. AU - Garcia-Garcia, A. AU - Panayiotidis, M. I. AU - Franco, R. PY - 2011 DA - 2011// TI - DNA damage and autophagy JO - Mutat Res VL - 711 UR - https://doi.org/10.1016/j.mrfmmm.2011.03.007 DO - 10.1016/j.mrfmmm.2011.03.007 ID - Rodriguez-Rocha2011 ER - TY - JOUR AU - Liu, C. AU - Yan, X. AU - Wang, H. -. Q. AU - Gao, Y. -. Y. AU - Liu, J. AU - Hu, Z. PY - 2012 DA - 2012// TI - Autophagy-independent enhancing effects of Beclin 1 on cytotoxicity of ovarian cancer cells mediated by proteasome inhibitors JO - BMC Cancer VL - 12 UR - https://doi.org/10.1186/1471-2407-12-622 DO - 10.1186/1471-2407-12-622 ID - Liu2012 ER - TY - JOUR AU - Levine, B. AU - Yuan, J. PY - 2005 DA - 2005// TI - Autophagy in cell death: an innocent convict? JO - J Clin Invest VL - 115 UR - https://doi.org/10.1172/JCI26390 DO - 10.1172/JCI26390 ID - Levine2005 ER - TY - JOUR AU - Opipari, A. W. AU - Tan, L. AU - Aurora, A. AU - Liu, J. R. AU - Boitano, A. E. AU - Sorenson, D. R. PY - 2004 DA - 2004// TI - Resveratrol-induced autophagocytosis in ovarian Cancer cells JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-2404 DO - 10.1158/0008-5472.CAN-03-2404 ID - Opipari2004 ER - TY - JOUR AU - Wan, B. AU - Dai, L. AU - Wang, L. AU - Zhang, Y. AU - Huang, H. AU - Qian, G. PY - 2018 DA - 2018// TI - Knockdown of BRCA2 enhances cisplatin and cisplatin-induced autophagy in ovarian cancer cells JO - Endocr Relat Cancer VL - 25 UR - https://doi.org/10.1530/ERC-17-0261 DO - 10.1530/ERC-17-0261 ID - Wan2018 ER - TY - JOUR AU - Banno, K. AU - Yanokura, M. AU - Iida, M. AU - Adachi, M. AU - Nakamura, K. AU - Nogami, Y. PY - 2014 DA - 2014// TI - Application of microRNA in diagnosis and treatment of ovarian cancer JO - Biomed Res Int VL - 2014 UR - https://doi.org/10.1155/2014/232817 DO - 10.1155/2014/232817 ID - Banno2014 ER - TY - JOUR AU - Muralidhar, G. G. AU - Barbolina, M. V. PY - 2015 DA - 2015// TI - The miR-200 family: versatile players in epithelial ovarian cancer JO - Int J Mol Sci VL - 16 UR - https://doi.org/10.3390/ijms160816833 DO - 10.3390/ijms160816833 ID - Muralidhar2015 ER - TY - JOUR AU - Chen, S. N. AU - Chang, R. AU - Lin, L. AU - Chern, C. U. AU - Tsai, H. W. AU - Wen, Z. H. PY - 2019 DA - 2019// TI - MicroRNA in ovarian cancer: biology, pathogenesis, and therapeutic opportunities JO - Int J Environ Res Public Health VL - 16 ID - Chen2019 ER - TY - JOUR AU - Marchini, S. AU - Cavalieri, D. AU - Fruscio, R. AU - Calura, E. AU - Garavaglia, D. AU - Nerini, I. F. PY - 2011 DA - 2011// TI - Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70012-2 DO - 10.1016/S1470-2045(11)70012-2 ID - Marchini2011 ER - TY - JOUR AU - Cochrane, D. R. AU - Spoelstra, N. S. AU - Howe, E. N. AU - Nordeen, S. K. AU - Richer, J. K. PY - 2009 DA - 2009// TI - MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents JO - Mol Cancer Ther VL - 8 UR - https://doi.org/10.1158/1535-7163.MCT-08-1046 DO - 10.1158/1535-7163.MCT-08-1046 ID - Cochrane2009 ER - TY - JOUR AU - Cittelly, D. M. AU - Dimitrova, I. AU - Howe, E. N. AU - Cochrane, D. R. AU - Jean, A. AU - Spoelstra, N. S. PY - 2012 DA - 2012// TI - Restoration of miR-200c to ovarian Cancer reduces tumor burden and increases sensitivity to paclitaxel JO - Mol Cancer Ther VL - 11 UR - https://doi.org/10.1158/1535-7163.MCT-12-0463 DO - 10.1158/1535-7163.MCT-12-0463 ID - Cittelly2012 ER -